DYAX – The simplest explanation is that GENZ does not think DX-88 can compete with the HAE offerings from Pharming and ABT/Jerini. That’s my take—at least until the CC tomorrow
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.